phosphoserine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Phosphoserine: The phosphoric acid ester of serine.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Ye, C | 1 |
| Cheng, Q | 1 |
| Zhang, X | 1 |
| Yao, L | 1 |
| Li, Q | 1 |
| Huang, J | 1 |
| Liu, Y | 1 |
| Zou, Z | 1 |
| Wang, H | 1 |
| Yan, J | 1 |
| Zhu, Y | 1 |
| Wang, C | 1 |
| Ai, D | 1 |
| Mardinoglu, A | 1 |
| Agren, R | 1 |
| Kampf, C | 1 |
| Asplund, A | 1 |
| Uhlen, M | 1 |
| Nielsen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters: A Clinical and Ex-vivo Study.[NCT03850314] | Phase 2/Phase 3 | 50 participants (Anticipated) | Interventional | 2019-03-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for phosphoserine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis.
Topics: Animals; Apoptosis; Calcium; Cholesterol; Choline; Diet; Disease Progression; Dynamins; Feeding Beha | 2019 |
Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease.
Topics: Adolescent; Adult; Aged; Biomarkers; Chondroitin; Databases, Genetic; Female; Genome; Glycine Hydrox | 2014 |